PureTech Health plc (PRTC)
NASDAQ: PRTC · IEX Real-Time Price · USD
27.90
0.00 (0.00%)
At close: May 17, 2024, 12:00 AM
29.05
+1.15 (4.12%)
Pre-market: May 20, 2024, 8:34 AM EDT

PureTech Health Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for PureTech Health.

Analyst Consensus: n/a
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

There are currently no analyst ratings available for PRTC.

Recommendation Trends

Rating Mar '22Apr '22May '22Jun '22Jul '22Aug '22
Strong Buy 000000
Buy 111110
Hold 000000
Sell 000000
Strong Sell 000000
Total 111110

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Buy
Maintains
$37$44
Buy Maintains $37$44 +57.71% Aug 25, 2022
SVB Leerink
SVB Leerink
Buy
Maintains
$66$70
Buy Maintains $66$70 +150.90% Aug 9, 2022
SVB Leerink
SVB Leerink
Buy
Maintains
$70$66
Buy Maintains $70$66 +136.56% Jun 15, 2022
SVB Leerink
SVB Leerink
Buy
Maintains
$76$70
Buy Maintains $76$70 +150.90% Jan 7, 2022
SVB Leerink
SVB Leerink
Buy
Maintains
n/a
Buy Maintains n/a n/a Aug 25, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 3.33M
Revenue Next Year
n/a
EPS This Year
-0.89
from -2.40
EPS Next Year
-0.96
from -0.89
Year 2019202020212022202320242025202620272028
Revenue
9.81M11.77M17.39M15.62M3.33M--27.98M238.66M487.63M
Revenue Growth
-52.73%20.00%47.76%-10.18%-78.68%---753.06%104.32%
EPS
14.400.20-2.10-1.80-2.40-0.89-0.96-0.71--
EPS Growth
--98.61%--------
No. Analysts -----22222
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a 49.6M 248.1M 506.9M
Avg n/a n/a 28.0M 238.7M 487.6M
Low n/a n/a 8.0M 231.6M 473.1M

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
786.9%
112.4%
Avg - - -
753.1%
104.3%
Low - - -
727.7%
98.2%

EPS Forecast

EPS 202420252026
High -0.92 -1.00 -0.74
Avg -0.89 -0.96 -0.71
Low -0.86 -0.93 -0.69

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.